Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783702 · ClinicalTrials.gov registry record · Phase 4
Pain Control Following Sinus Surgery
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 118
- Enrollment target
NCT03783702: Completed Phase 4 study, sponsored by Stanford University.
NCT03783702 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 118 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03783702, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 118 participants
- Enrollment target
Study Summary
Given the ongoing national opioid epidemic, an increased interest has developed in optimizing opioid prescribing practices of physicians, including otolaryngologists. Endoscopic sinus surgery (ESS) is one of the most commonly performed surgeries by otolaryngologists with over 250,000 ESS's performed annually in the U.S. Multiple studies have shown that, compared to the amount patients actually consume, otolaryngologists prescribe a high quantity of opioids to patients recovering from ESS). It has been shown that these excess opioid medications contribute to prolonged use or abuse by the patient, family members, or friends. The purpose of this study is to better understand the pain management requirements of patients who undergo ESS for recurrent acute rhinosinusitis (RARS) or chronic rhinosinusitis (CRS). This prospective, randomized, multi-institutional controlled trial will aim to determine the degree to which pain following ESS can be adequately controlled by non-opioid medications. It will also determine whether post-ESS narcotic use can be avoided entirely, or at least significantly limited. Patients will be randomized into two groups, each of which will receive a stepwise analgesic regimen consisting of acetaminophen and oxycodone or acetaminophen and ibuprofen. Pain will be assessed daily using visual analog scales (VAS) and the Brief Pain Inventory (BPI). The results of this study will help to develop a standardized approach to pain management in the post-ESS setting and help to elucidate the role of non-opioid pain medications. The ultimate goal would be to positively affect opioid prescribing patterns among surgeons who perform ESS in order to significantly reduce the quantity of opioids prescribed to patients while continuing to adequately manage patients' pain.
Interventions
- DRUG OxyCODONE 5 Mg (milligram) Oral Tablet
- DRUG Ibuprofen 600 Mg (milligram) Oral Tablet
- DRUG Acetaminophen 650 MG (milligram) Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2020-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03783702
The ClinicalTrials.gov registry entry for NCT03783702 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which OxyCODONE 5 Mg (milligram) Oral Tablet is the first listed.
NCT03783702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03783702 about?
NCT03783702 is a clinical study titled "Pain Control Following Sinus Surgery". Given the ongoing national opioid epidemic, an increased interest has developed in optimizing opioid prescribing practices of physicians, including otolaryngologists. Endoscopic sinus surgery (ESS) is one of the most commonly performed surgeries by otolaryngologists with over 250,000 ESS's performed...
What is the current status of trial NCT03783702?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 118 participants. The study started on 2019-04-04. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT03783702?
The interventions under investigation include: OxyCODONE 5 Mg (milligram) Oral Tablet (DRUG), Ibuprofen 600 Mg (milligram) Oral Tablet (DRUG), Acetaminophen 650 MG (milligram) Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT03783702?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.